deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03424941

The TransCatheter Valve and Vessels Trial (TCW)

TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Versus Conventional Surgical Aortic Valve Replacement and Coronary By-Pass Grafts for Treatment of Patients with Coronary MultiVessel Disease and Aortic Valve Stenosis

Sponsor: Maatschap Cardiologie Zwolle

Conditions Aortic Stenosis CABG Fractional Flow Reserve Multi Vessel Coronary Artery Disease PCI TAVI
Interventions CABG and SAVR FFR-guided PCI and TAVI
Updated 16 times since 2018 Last updated: Jan 7, 2025 Started: May 31, 2018 Primary completion: Jun 26, 2024 Completion: Jun 26, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Aortic Stenosis and CABG and is currently completed. Maatschap Cardiologie Zwolle leads this study, which shows 16 recorded versions since 2018 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Jan 2019 · 4 months · monthly snapshot~Jan 2019 – ~Jul 2019 · 6 months · monthly snapshot~Jul 2019 – ~Dec 2019 · 5 months · monthly snapshot~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~May 2021 · 2 months · monthly snapshot~May 2021 – ~Sep 2022 · 16 months · monthly snapshot~Sep 2022 – ~Mar 2024 · 18 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Feb 2025 — Sep 2025 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  3. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  5. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

▶ Show 11 earlier versions

  1. Sep 2022 — Mar 2024 [monthly]

    Recruiting NA

  2. May 2021 — Sep 2022 [monthly]

    Recruiting NA

  3. Mar 2021 — May 2021 [monthly]

    Recruiting NA

  4. Jan 2021 — Mar 2021 [monthly]

    Recruiting NA

  5. Dec 2019 — Jan 2021 [monthly]

    Recruiting NA

  6. Jul 2019 — Dec 2019 [monthly]

    Recruiting NA

  7. Jan 2019 — Jul 2019 [monthly]

    Recruiting NA

  8. Sep 2018 — Jan 2019 [monthly]

    Recruiting NA

  9. Jun 2018 — Sep 2018 [monthly]

    Recruiting NA

  10. Apr 2018 — Jun 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  11. Mar 2018 — Apr 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Maatschap Cardiologie Zwolle
  • Medtronic
Data source: Maatschap Cardiologie Zwolle

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amsterdam, Netherlands , Banská Bystrica, Slovakia , Bordeaux, France , Copenhagen, Denmark , Graz, Austria , Groningen, Netherlands , Hamburg, Germany , Kallithea, Greece , Katowice, Poland , Lille, France and 10 more locations